MTOR and myelodysplastic syndrome: Meanwhile, activation of the PI3K/Akt/mTOR pathway contributes to chemoresistance in AML and MDS by enhancing glycolysis and lipid synthesis while suppressing autophagy, ultimately reducing chemotherapy-induced cell death (100).